Validity of the French Version of the Child’s Vestibular Disorder Symptoms Questionnaire

Overview

There is currently no score in French for evaluating disorders of the child's balance. Only one questionnaire was validated in the child in English in 2016, the " Pediatric Vestibular Symptom Questionnaire ". The objective of the research is to validate the French translation of this questionnaire.

Full Title of Study: “Validity of the French Version of the Child’s Vestibular Disorder Symptoms Questionnaire”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 2021

Detailed Description

Balance disorders are the most common cause of dizziness in children with a prevalence of 0.7 to 15%. Vestibular migraine, benign paroxysmal positional vertigo of the child, post-concussion dizziness as a result of cranial trauma, and viral vestibular neuritis are the most common causes. However, these disorders are often undiagnosed in children as many doctors may attribute these symptoms to behavioural disorders or clumsiness. This is probably because of the difficulty children may have in expressing or describing their dizziness symptoms without specific questioning, but also because of the tendency of children to accept the terminology that an adult offers them or even tend to cling to their parents when they experience a balance disorder or vertigo. Vestibular disorders can also have secondary psychological symptoms with an impact on school learning and quality of life. A precise interrogation to check the symptoms, to look for the triggers and to trace the installation of the symptoms is fundamental to diagnose and make a therapeutic decision. Thus, it is very important to help the child express his or her feelings by proposing different descriptions and formulations to determine the etiology and diagnosis. While a number of international questionnaires validated and translated into French exist in the adult to assess the presence, severity and impact of vestibular symptoms, there is currently no score in French for evaluating disorders of the child's balance. Only one questionnaire was validated in the child in English in 2016, the " Pediatric Vestibular Symptom Questionnaire ". The objective of the research is to validate the French translation of this questionnaire.

Interventions

  • Other: Pediatric Vestibular Symptom Questionnaire
    • Subjects respond to the translated questionnaire twice with 15 days interval

Arms, Groups and Cohorts

  • Patients
    • Patients from 7 to 17 years of age with vestibular deficiency.
  • Controls
    • Subjects from 7 to 17 years of age without vestibular deficiency

Clinical Trial Outcome Measures

Primary Measures

  • Reproducibility
    • Time Frame: 1 year
    • Reproducibility of the questionnaire completed by a subject at 15 days apart. Student t-test.
  • Consistency reliability test
    • Time Frame: 1 year
    • Measure of efficiency. Comparison of questionnaires completed by patients and controls.
  • Item-total Pearson correlation
    • Time Frame: 1 year
    • Measure of efficiency. Comparison of questionnaires completed by patients and controls.
  • Principal components analysis
    • Time Frame: 1 year
    • Measure of efficiency. Comparison of questionnaires completed by patients and controls.

Participating in This Clinical Trial

Inclusion Criteria

  • Non-opposition of the holders of parental authority and the subject to participation in the study
  • Subjects between 7 and 17 years of age
  • Patients : patients followed in the clinic at Necker Hospital in pediatric department of otolaryngology and cervico-facial surgery and presenting with dizziness without associated ophthalmological or neurological disorder.
  • Controls : subject with no vestibular deficiency, symptoms of balance disorder, migraine, otological pathology or ophthalmological disorder at the time of inclusion or background.

Exclusion Criteria

  • Absence of diagnosis after etiological assessment.

Gender Eligibility: All

Minimum Age: 7 Years

Maximum Age: 17 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Assistance Publique – Hôpitaux de Paris
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • François Simon, MD MSc, Principal Investigator, Assistance Publique – Hôpitaux de Paris
  • Overall Contact(s)
    • François Simon, MD MSc, +33144381872, f.simon@aphp.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.